|67.16||+0.1900||+0.28%||Vol 529.20K||1Y Perf 82.05%|
|Apr 20th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||60.44||Analyst Rating||Moderate Buy 2.17|
|Potential %||-10.01||Finscreener Ranking||☆ 37.00|
|Insiders Trans % 3/6/12 mo.||-100/-100/-83||Value Ranking||★ 41.12|
|Insiders Value % 3/6/12 mo.||-100/-100/-35||Growth Ranking||★★+ 50.75|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-61||Income Ranking||+ 28.53|
|Market Cap||10.18B||Earnings Rating||Buy|
|Price Range Ratio 52W %||90.37||Earnings Date||5th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||5th May 2021|
|Estimated EPS Next Report||0.32|
|EPS Growth Next 5 Years %||6.70|
|Avg. Weekly Volume||558.52K|
|Avg. Monthly Volume||437.11K|
|Avg. Quarterly Volume||461.83K|
Bruker Corporation (NASDAQ: BRKR) stock closed at 67.16 per share at the end of the most recent trading day (a 0.28% change compared to the prior day closing price) with a volume of 533.41K shares and market capitalization of 10.18B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7230 people. Bruker Corporation CEO is Frank H. Laukien.
The one-year performance of Bruker Corporation stock is 82.05%, while year-to-date (YTD) performance is 24.07%. BRKR stock has a five-year performance of 134.13%. Its 52-week range is between 34.79 and 70.61, which gives BRKR stock a 52-week price range ratio of 90.37%
Bruker Corporation currently has a PE ratio of 65.70, a price-to-book (PB) ratio of 10.67, a price-to-sale (PS) ratio of 6.49, a price to cashflow ratio of 31.50, a PEG ratio of 2.32, a ROA of 5.20%, a ROC of 10.28% and a ROE of 16.20%. The company’s profit margin is 9.86%, its EBITDA margin is 16.10%, and its revenue ttm is $1.56 Billion , which makes it $10.32 revenue per share.
Of the last four earnings reports from Bruker Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.32 for the next earnings report. Bruker Corporation’s next earnings report date is 05th May 2021.
The consensus rating of Wall Street analysts for Bruker Corporation is Moderate Buy (2.17), with a target price of $60.44, which is -10.01% compared to the current price. The earnings rating for Bruker Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Bruker Corporation has a dividend yield of 0.24% with a dividend per share of $0.16 and a payout ratio of 15.00%.
Bruker Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 14.40, ATR14 : 2.32, CCI20 : 41.50, Chaikin Money Flow : 0.01, MACD : 2.08, Money Flow Index : 62.03, ROC : 4.18, RSI : 46.47, STOCH (14,3) : 51.92, STOCH RSI : 0.00, UO : 50.19, Williams %R : -48.08), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Bruker Corporation in the last 12-months were: Burkhard Prause (Option Excercise at a value of $110 950), Burkhard Prause (Sold 5 000 shares of value $239 650 ), Cynthia M. Friend (Option Excercise at a value of $62 808), Cynthia M. Friend (Sold 13 473 shares of value $651 628 ), Frank H. Laukien (Buy at a value of $97 775), Gilles G. Martin (Option Excercise at a value of $240 000), Gilles G. Martin (Sell at a value of $1 164 951), Marc A. Kastner (Sold 1 236 shares of value $69 908 ), William A. Linton (Option Excercise at a value of $96 540)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.